参考文献/References:
[1] Tamis-Holland JEJneid H,Reynolds HR,et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease:a scientific statement from the American Heart Association[J]. Circulation,2019,139(18):e891-e908.
[2] Collet JP,Thiele H,Barbato E,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J,2021,42(14):1289-1367.
[3] Basmah S,Spatz ES,Dreyer RP,et al. Presentation,clinical profile,and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA):results from the VIRGO study[J]. J Am Heart Assoc,2018,7(13):e009174.
[4] Pasupathy S,Air T,Dreyer RP,et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries[J]. Circulation,2015,131(10):861-870.
[5] Thygesen K,Alpert JS,Jaffe AS,et al. Fourth universal definition of myocardial infarction (2018)[J]. J Am Coll Cardiol,2018,72(18):2231-2264.
[6] Bentzon JF,Otsuka F,Virmani R,et al. Mechanisms of plaque formation and rupture[J]. Circ Res,2014,114(12):1852-1866.
[7] Ghadri JR,Cammann VL,Napp LC,et al. Differences in the clinical profile and outcomes of typical and atypical Takotsubo syndrome:data from the international Takotsubo registry[J]. JAMA Cardiol,2016,1(3):335-340.
[8] Scalone G,Niccoli G,Crea F. Editor’s choice- pathophysiology,diagnosis and management of MINOCA:an update[J]. Eur Heart J Acute Cardiovasc Care,2019,8(1):54-62.
[9] Eitel I,von Knobelsdorff-Brenkenhoff F,Bernhardt P,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy[J]. JAMA,2011,306(3):277-286.
[10] Scanlon PJ,Faxon DP,Audet AM,et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions[J]. Circulation,1999,99(17):2345.
[11] Nallamothu BK,Spertus JA,Lansky AJ,et al. Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice:the Assessing Angiography (A2) project[J]. Circulation,2013,127(17):1793-1800.
[12] Hanratty CG,Koyama Y,Rasmussen HH,et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction:implications for immediate multivessel revascularization[J]. J Am Coll Cardiol,2002,40(5):911-916.
[13] Curzen N,Rana O,Nicholas Z,et al. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?:the RIPCORD study[J]. Circ Cardiovasc Interv,2014,7(2):248-255.
[14] Ong P,Camici PG,Beltrame JF,et al. International standardization of diagnostic criteria for microvascular angina[J]. Int J Cardiol,2018,250:16-20.
[15] Tearney GJ,Regar E,Akasaka T,et al. Consensus standards for acquisition,measurement,and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation[J]. J Am Coll Cardiol,2012,59(12):1058-1072.
[16] Mariani J Jr,Guedes C,Soares P,et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention:the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial[J]. JACC Cardiovasc Interv,2014,7(11):1287-1293.
[17] Hafiz AM,Jan MF,Mori N,et al. Prevention of contrast‐induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions:Randomized comparison of two preventive strategies[J]. Catheter Cardio Inte,2012,79(6):929-937.
[18] Reynolds HR,Maehara A,Kwong RY,et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women[J]. Circulation,2021,143(7):624-640.
[19] Citro R,Okura H,Ghadri JR,et al. Multimodality imaging in takotsubo syndrome:a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE)[J]. J Echocardiogr,2020,18(4):199-224.
[20] Kindermann I,Barth C,Mahfoud F,et al. Update on myocarditis[J]. J Am Coll Cardiol,2012,59(9):779-792.
[21] Gr?ni C,Eichhorn C,Bière L,et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk?stratifying patients with suspected?myocarditis[J]. J Am Coll Cardiol,2017,70(16):1964-1976.
[22] Tornvall P,Gerbaud E,Behaghel A,et al. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease:a meta-analysis of individual patient data[J]. Atherosclerosis,2015,241(1):87-91.
[23] Ferreira VM,Schulz-Menger J,Holmvang G,et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation:expert recommendations[J]. J Am Coll Cardiol,2018,72(24):3158-3176.
[24] Ferreira VM,Piechnik SK,Dall’Armellina E,et al. Native T1-mapping detects the location,extent and patterns of acute myocarditis without the need for gadolinium contrast agents[J]. J Cardiovasc Magn Reson,2014,16(1):36.
[25] Lurz P,Luecke C,Eitel I,et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis[J]. J Am Coll Cardiol,2016,67(15):1800-1811.
[26] Radunski UK,Lund GK,S?ring D,et al. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis[J]. Clin Res Cardiol,2017,106(1):10-17.
[27] Kostakou PM,Kostopoulos VS,Tryfou ES,et al. Subclinical left ventricular dysfunction and correlation with regional strain analysis in myocarditis with normal ejection fraction. A new diagnostic criterion[J]. Int J Cardiol,2018,259:116-121.
[28] Chen X,Hu H,Pan J,et al. Performance of cardiovascular magnetic resonance strain in patients with acute myocarditis[J]. Cardiovasc Diagn Ther,2020,10(4):725-737.
[29] Luetkens JA,Schlesinger-Irsch U,Kuetting DL,et al. Feature-tracking myocardial strain analysis in acute myocarditis:diagnostic value and association with myocardial oedema[J]. Eur Radio,2017,27(11):4661-4671.
[30] Eichhorn C,Greulich S,Bucciarelli-Ducci C,et al. Multiparametric cardiovascular magnetic resonance approach in diagnosing,monitoring,and prognostication of?myocarditis[J]. JACC Cardiovasc Imaging,2022,15(7):1325-1338.
[31] Plácido R,Cunha Lopes B,Almeida AG,et al. The role of cardiovascular magnetic resonance in takotsubo syndrome[J]. J Cardiovasc Magn Reson,2016,18(1):68.
[32] Taqueti VR,Carli M. Coronary microvascular disease pathogenic mechanisms and therapeutic options[J]. J Am Coll Cardiol,2018,72(21):2625-2641.
[33] Murthy VL,Naya M,Taqueti VR,et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes[J]. Circulation,2014,129(24):2518-2527.
[34] Driessen RS,Raijmakers PG,Stuijfzand WJ,et al. Myocardial perfusion imaging with PET[J]. Int J Cardiovasc Imaging,2017,33(7):1021-1031.
[35] Ghadri JR,Wittstein IS,Prasad A,et al. International expert consensus document on Takotsubo syndrome (Part II):diagnostic workup,outcome,and management[J]. Eur Heart J,2018,39(22):2047-2062.
[36] Occhipinti G,Bucciarelli-Ducci C,Capodanno D. Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)[J]. Eur Heart J Acute Cardiovasc Care,2021,10(7):813-822.
[37] Arslan F,Bongartz L,Ten Berg JM,et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:comments from the Dutch ACS working group[J]. Neth Heart J,2018,26(9):417-421.
相似文献/References:
[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(9):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
[2]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[3]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(9):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[4]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(9):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[5]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(9):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[6]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(9):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[7]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(9):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[8]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(9):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[9]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(9):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[10]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(9):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[11]胥日,羊镇宇.冠状动脉非阻塞性心肌梗死的发病机制[J].心血管病学进展,2021,(2):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
XU Ri,YANG Zhenyu.Pathogenesis and Imaging Manifestations of Myocardial Infarction with Non-obstructive Coronary Arteries[J].Advances in Cardiovascular Diseases,2021,(9):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]